Daniel Cohn

Daniel Cohn is a Professor in the Department of Human Genetics at the David Geffen School of Medicine, University of California, Los Angeles. His research spans over two decades with a primary focus on the genetic basis of skeletal dysplasias and connective tissue disorders. He has established himself as a leading expert in osteogenesis imperfecta, collagen biology, and chondrocyte development through extensive collaborative research.

Dr. Cohn's research interests center on skeletal dysplasias, osteogenesis imperfecta, and the molecular mechanisms underlying genetic bone disorders. His work has significantly advanced our understanding of collagen biosynthesis, extracellular matrix organization, and chondrocyte biology. He investigates how mutations in genes encoding structural proteins and signaling molecules lead to skeletal malformations, with particular emphasis on ciliopathies and disorders involving collagen and other extracellular matrix components.

Analysis of Dr. Cohn's publication record reveals a consistent focus on genetic skeletal disorders, with particular emphasis on molecular mechanisms of disease. His work spans basic science investigations of chondrocyte biology and collagen biosynthesis to clinical classifications of skeletal dysplasias. A notable trend is his contribution to multiple revisions of the nosology of genetic skeletal disorders, demonstrating his leadership in standardizing classification systems for these conditions. His research increasingly incorporates advanced genomic techniques and mouse models to elucidate disease mechanisms.

Dr. Cohn has been instrumental in identifying numerous disease-causing genes for skeletal dysplasias and has contributed significantly to understanding the molecular pathways involved in skeletal development and maintenance. His work bridges basic science and clinical applications, providing insights that have implications for diagnosis and potential therapeutic approaches for patients with genetic bone disorders.